期刊文献+

米力农对瓣膜置换术病人围术期肌钙蛋白Ⅰ的影响

Influence of Milrinone on Treponin I in Patients Undergoing Cardiac Valve Replacement
暂未订购
导出
摘要 目的研究瓣膜置换病人围术期的心肌损害程度及米力农对其的影响。方法20例心功能Ⅱ级~Ⅲ级瓣膜置换术病人,随机分为米力农组和对照组,主动脉开放即刻米力农组10min内用负荷剂量米力农50μg/kg、继以0.5μg/(kg·min)持续静脉输注,对照组则只给予生理盐水。分别于麻醉诱导后开胸手术前(T0)、主动脉开放后30min(T1)、6h(T2)、24h(T3)取中心静脉血,免疫荧光法检测血清肌钙蛋白Ⅰ(cTnⅠ)。结果两组T1、T2、T3cTnⅠ均明显升高,米力农组cTnⅠ在T1、T2、T3显著低于对照组(P〈0.05)。结论体外循环下瓣膜置换术应用米力农能够有效减轻心肌损伤程度。 Objective To investigate the myocardial injury and the influence of milrinone on Treponin I in the perioperative cardiac valve replacement. Methods Twenty patients (pts) with heart function of NYttA class Ⅱ or Ⅲ, scheduled for cardiac valve replacement were randomly divided into 2 groups: Milrinone group and control group. Milrinone 50 μg/kg was given in i0 min immediately after unclamping of aortic and followed by a continuous infusion of 0.5 μg/(kg · min) during operation in milrinone group for 24 h after operation. The ,same volume of saline was administrated in Control group. The venous blood samples were obtained from the central vein at the following points: before operation (To) ; 30 rain after unclamping of aorta (T1) 6 h (T2) and 24 h (T3) after unclamping of aorta. Results Compared with that at To, the levels of CTn Ⅰ increased significantly from T1 to T3 ( P 〈 0.05) in both groups. Compared with that in control group, CTn Ⅰ level increased obviously (P 〈 0.05) in milrinone group from T1 to T3. Conclusion During cardiac valve replacement, milrinone was effective for myocardial preservation.
出处 《中西医结合心脑血管病杂志》 2006年第11期949-950,共2页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
关键词 米力农 瓣膜置换 肌钙蛋白Ⅰ Milrinone cardiac valve replacement cTn Ⅰ
  • 相关文献

参考文献7

  • 1Jess D,Schwartz MD,Peter S,et al.Cardiopulmonary bypass primes polymorphonuclear leukocytes[J].Surg Res,1998,75:177-182.
  • 2Hoffman TM,Wernovsky G,Atz AM,et al.Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease[J].Circulation,2003,107(7):996-1002.
  • 3Thomas MH,Heinz ML,Hugo VA,et al.Milrinone modulates endotoxemia,systemic inflammation,and subsequent acute phase response after cardiopulmonary bypass[J].Anesthesiology,1999,90:72 -80.
  • 4Adams JE,Bodor GS,Davila-Roman VG,et al.Cardiac troponin I,a marker with high specificity for cardiac injury[J].Circulation,1993,88:101-106.
  • 5Kikura M,Sato S.The efficacy of preemptive Milrinone or Amrinone therapy in patients undergoing coronary artery bypass grafting[J].Anesth Analg,2002,94(1):22-30.
  • 6陈艳平,曹德权,明豫军,常业恬.米力农对体外循环期间胃肠灌注的影响[J].中华麻醉学杂志,2001,21(11):656-658. 被引量:5
  • 7Bailey JM,Levy JH,Kikura M,et al,Pharmacokinetic of intravenous milrinone in patients undergoing cardiac surgery[J].Anesthesiology,1994,81:616-622.

二级参考文献3

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部